GOBankingRates on MSN
I’m a financial advisor: Here are 12 retirement mistakes that cost clients $100K or more
Financial advisors revealed 12 retirement mistakes costing over $100k: claiming Social Security early, ignoring taxes, poor cash flow planning and healthcare.
The departure of a community’s major employer is about more than job losses. Finance managers need a fiscal strategy.
Xiang discusses how some big companies like NCP are so dependent on debt that they can’t adjust to change. Erwei (David) Xiang, Newcastle University When the UK’s biggest private car park company went ...
Community Healthcare (CHCT) offers an 11.6% yield and discounted valuation, but faces tenant uncertainty, flat AFFO growth, and high leverage. See more.
Jason Fernando is a professional investor and writer who enjoys tackling and communicating complex business and financial ...
When you have a lot of bills to pay, and your business isn't bringing in much money, you might feel stressed. Before taking a term loan for your cash flow, plan how you'll use the money. You can give ...
This article was paid for by Intuit QuickBooks. Operating a successful business often comes down to how well you track and manage cash flow, or the money coming in and out of your business. Jen ...
Upwork reports small businesses face challenges like cash flow, rising costs, and talent retention, advocating for resilience, automation, and strategic partnerships.
This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them. On a March 2026 episode of The Dave Ramsey Show, a caller ...
Less than eight months after it launched, Row K Entertainment, a new Hollywood distribution label, is being beset with unpaid bills and concerns about its finances. Eight sources from outside the ...
Many startups run into cash flow problems even when revenue is growing. These issues usually don’t come from one bad decision, but from everyday operational choices—how revenue is collected, how ...
Tesla’s “Terafab” semiconductor ambitions to launch this week carry an estimated price tag of $25-40 billion. The math is getting hard to reconcile with a company that generated just $6.2 billion in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results